A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation

被引:61
|
作者
Keller, Dagmar I.
Huang, Hai
Zhao, Juan
Frank, Rudolf
Suarez, Vivian
Delacretaz, Etienne
Brink, Marijke
Osswald, Stefan
Schwick, Nicola
Chahine, Mohamed
机构
[1] Hop Laval, Quebec Heart Inst, Res Ctr, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Basel Hosp, Cardiobiol Res Grp, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland
[4] Tiefenau Hosp, Dept Cardiol, Bern, Switzerland
[5] Swiss Cardiovasc Ctr, Bern, Switzerland
基金
加拿大健康研究院;
关键词
Brugada syndrome; sudden cardiac death; genetics; SCN5A; sodium channel; Na(v)1.5; fever; ventricular fibrillation;
D O I
10.1016/j.cardiores.2006.02.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Brugada syndrome (BS) is an inherited electrical cardiac disorder characterized by right bundle branch block pattern and ST segment elevation in leads V1 to V3 on surface electrocardiogram that can potentially lead to malignant ventricular tachycardia and sudden cardiac death. About 20% of patients have mutations in the only so far identified gene, SCN5A, which encodes the alpha-subunit of the human cardiac voltage-dependent sodium channel (hNa(v)1.5). Fever has been shown to unmask or trigger the BS phenotype, but the associated molecular and the biophysical mechanisms are still poorly understood. We report on the identification and biophysical characterization of a novel heterozygous missense mutation in SCN5A, F1344S, in a 42-year-old male patient showing the BS phenotype leading to ventricular fibrillation during fever. Methods: The mutation was reproduced in vitro using site-directed mutagenesis and characterized using the patch clamp technique in the whole-cell configuration. Results: The biophysical characterization of the channels carrying the F1344S mutation revealed a 10mV mid-point shift of the G/V curve toward more positive voltages during activation. Raising the temperature to 40.5 degrees C further shifted the mid-point activation by 18mV and significantly changed the slope factor in Na(v)1.5/F1344S mutant channels from -6.49 to -10.27 mV. Conclusions: Our findings indicate for the first time that the shift in activation and change in the slope factor at a higher temperature mimicking fever could reduce sodium currents' amplitude and trigger the manifestation of the BS phenotype. (c) 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:521 / 529
页数:9
相关论文
共 45 条
  • [31] Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family
    Kyndt, F
    Probst, V
    Potet, F
    Demolombe, S
    Chevallier, JC
    Baro, I
    Moisan, JP
    Boisseau, P
    Schott, JJ
    Escande, D
    Le Marec, H
    CIRCULATION, 2001, 104 (25) : 3081 - 3086
  • [32] A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs
    Itoh, H
    Shimizu, M
    Takata, S
    Mabuchi, H
    Imoto, K
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (05) : 486 - 493
  • [33] Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation
    Hasebe, Hideyuki
    Yokoya, Tomoyo
    Murakoshi, Nobuyuki
    Kurebayashi, Nobutake
    INTERNAL MEDICINE, 2020, 59 (01) : 83 - 87
  • [34] Novel SCN5A frame-shift mutation underlying in patient with idiopathic ventricular fibrillation manifested with J wave in inferior lead and prolonged S-wave in precordial lead
    Zhou, Xiaoqian
    Ren, Lan
    Huang, Jian
    Zhang, Yinhui
    Cai, Ying
    Pu, Jielin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (06)
  • [35] A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia
    Tan, Bi-Hua
    Iturralde-Torres, Pedro
    Medeiros-Domingo, Argelia
    Nava, Santiago
    Tester, David J.
    Valdivia, Cannen R.
    Tusie-Luna, Teresa
    Ackernian, Michael J.
    Makielski, Jonathan C.
    CARDIOVASCULAR RESEARCH, 2007, 76 (03) : 409 - 417
  • [36] Novel SCN5A and GPD1L Variants Identified in Two Unrelated Han-Chinese Patients With Clinically Suspected Brugada Syndrome
    Yuan, Meng
    Guo, Yi
    Xia, Hong
    Xu, Hongbo
    Deng, Hao
    Yuan, Lamei
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [37] Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death
    Rossenbacker, T
    Carroll, SJ
    Liu, HJ
    Kuipéri, C
    de Ravel, TJL
    Devriendt, K
    Carmeliet, P
    Kass, RS
    Heidbüchel, H
    HEART RHYTHM, 2004, 1 (05) : 610 - 615
  • [38] Novel SCN5A gene mutation in a patient affected by multifocal ectopic premature Purkinje-related contractions syndrome
    Ventrella, Nicoletta
    Bianchini, Lorenzo
    Riva, Stefania
    Pizzamiglio, Francesca
    Dessanai, Maria Antonietta
    Tundo, Fabrizio
    Sattin, Tommaso
    De Lio, Francesca
    Cellucci, Selene
    Tondo, Claudio
    ESC HEART FAILURE, 2024, 11 (04): : 2399 - 2404
  • [39] Sick Sinus Syndrome, Progressive Cardiac Conduction Disease, Atrial Flutter and Ventricular Tachycardia Caused by a Novel SCN5A Mutation
    Holst, Anders G.
    Liang, Bo
    Jespersen, Thomas
    Bundgaard, Henning
    Haunso, Stig
    Svendsen, Jesper Hastrup
    Tfelt-Hansen, Jacob
    CARDIOLOGY, 2010, 115 (04) : 311 - 316
  • [40] Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope
    Makita, Naomasa
    Sumitomo, Naokata
    Watanabe, Ichiro
    Tsutsui, Hiroyuki
    HEART RHYTHM, 2007, 4 (04) : 516 - 519